2005
DOI: 10.1016/j.neures.2005.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein–vasopressin fusion gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 36 publications
0
4
0
1
Order By: Relevance
“…In this protocol, 0.25 m m V1a receptor antagonist was infused into the NTS at 0.25 μl h −1 . This dose was only 1/250th of previous studies in which the same antagonist, OPC‐21268, was infused into the lateral ventricle (Chu et al 2005; Kato et al 2009), and the infusion volume per hour was 1/800th of cerebrospinal fluid volume (Simchon et al 1999), suggesting that the effect of the antagonist was localized in the NTS and surrounding area. Therefore, our results from the V1a antagonist infusion suggest that V1a receptors in the NTS are involved in mediating baroreflex suppression in response to cerebral activation.…”
Section: Discussionmentioning
confidence: 79%
“…In this protocol, 0.25 m m V1a receptor antagonist was infused into the NTS at 0.25 μl h −1 . This dose was only 1/250th of previous studies in which the same antagonist, OPC‐21268, was infused into the lateral ventricle (Chu et al 2005; Kato et al 2009), and the infusion volume per hour was 1/800th of cerebrospinal fluid volume (Simchon et al 1999), suggesting that the effect of the antagonist was localized in the NTS and surrounding area. Therefore, our results from the V1a antagonist infusion suggest that V1a receptors in the NTS are involved in mediating baroreflex suppression in response to cerebral activation.…”
Section: Discussionmentioning
confidence: 79%
“…To determine whether this coupling could also be engaged by endogenous ATP, we challenged the PVN with a hyperosmotic stimulus. A large bulk of evidence in the literature supports the fact that a hyperosmotic challenge results in the activation of both magnocellular and parvocellular PVN neuronal populations (e.g., increased c-Fos expression) (Chu et al 2005;Sharp et al 1991). Moreover, a hyperosmotic challenge was also shown to increase PVN neuronal excitability and evoke a PVN-mediated sympathoexcitatory response and, consequently, an elevation in blood pressure (Antunes et al 2006;Chen and Toney 2001;Chu et al 2010;Son et al 2013).…”
Section: Discussionmentioning
confidence: 93%
“…Representative immunohistochemical data from these animals are presented in Figs. 3-6 with quantitative analysis of c-Fos expression summarized in Table 1. cerebroventricular administration of HS (21,66,76,97). The expected hormone release from terminals of magnocellular neurons in the pituitary resulted in elevated plasma levels of oxytocin and vasopressin correspondent with the prolonged rise in plasma osmolality, indicative of a role in restoring salt-water balance (9,114).…”
Section: Osmotic Stimulation Inhibits Glial and Perivascularvascular mentioning
confidence: 97%